Olema Pharmaceuticals, Inc.
OLMA
$10.63
$0.121.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 461.07M | 505.35M | 505.44M | 328.96M | 361.91M |
| Total Receivables | 3.17M | 3.35M | 4.06M | 2.97M | 2.75M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.64M | 4.53M | 4.37M | 1.82M | 2.64M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 1.59M | 577.00K | 423.00K |
| Total Current Assets | 469.88M | 513.23M | 515.45M | 334.33M | 367.73M |
|
|
|||||
| Total Current Assets | 469.88M | 513.23M | 515.45M | 334.33M | 367.73M |
| Net Property, Plant & Equipment | 1.02M | 1.28M | 1.42M | 1.91M | 2.25M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 784.00K | 838.00K | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.90M | 15.30M | 16.56M | 16.22M | 12.03M |
| Total Assets | 486.58M | 530.65M | 533.43M | 352.45M | 382.00M |
|
|
|||||
| Total Accounts Payable | 1.67M | 3.72M | 9.25M | 3.47M | 934.00K |
| Total Accrued Expenses | 50.67M | 42.49M | 41.43M | 37.01M | 31.08M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 660.00K | 956.00K | 1.12M | 1.17M | 1.15M |
| Total Finance Division Other Current Liabilities | 17.00K | -- | -- | -- | -- |
| Total Other Current Liabilities | 17.00K | -- | -- | -- | -- |
| Total Current Liabilities | 53.01M | 47.17M | 51.80M | 41.66M | 33.16M |
|
|
|||||
| Total Current Liabilities | 53.01M | 47.17M | 51.80M | 41.66M | 33.16M |
| Long-Term Debt | 3.00M | 3.00M | 3.00M | 3.00M | 3.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 69.00K | 310.00K | 602.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 56.01M | 50.17M | 54.87M | 44.97M | 36.77M |
|
|
|||||
| Common Stock & APIC | 1.15B | 1.13B | 1.08B | 858.46M | 854.20M |
| Retained Earnings | -713.85M | -650.65M | -597.56M | -551.50M | -509.28M |
| Treasury Stock & Other | -947.00K | -460.00K | 621.00K | 526.00K | 314.00K |
| Total Common Equity | 430.56M | 480.48M | 478.56M | 307.49M | 345.24M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 430.56M | 480.48M | 478.56M | 307.49M | 345.24M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 430.56M | 480.48M | 478.56M | 307.49M | 345.24M |
|
|
|||||